Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An update on the PRO CURE study, which is currently in the process of setting up.

PROCURE logo

New National Surgical Shoulder Trial (PRoCuRe Trial)

Professor Jonathan Rees and colleagues in the Surgical Intervention Trials Unit (SITU) have been awarded a £1.5 million National Institute of Health Research HTA grant to explore the benefits of surgical repair of partial rotator cuff tendon tears of the shoulder.

 

Rotator cuff problems are the most common cause of shoulder pain and disability, affecting people with day to day activities, work, recreation and sleep. These tears can be full tears through the whole tendon or only partially through. Partial tears are usually treated in the NHS first with physiotherapy and a steroid injection but then surgery if patient does not get better.

 

Professor Rees, Deputy Director at the Botnar Research Centre, NDORMS says: “Surgery for full tears is one of the most common shoulder operations in the UK but for partial tears, we still don’t know  if surgical repair gives patients a better result in the short term, or whether it prevents full tears developing in the long term. UK patients and surgeons have prioritised a need to answer this question which is why this trial has been funded by the HTA”

 

The study will take place across 20 NHS hospitals in the UK, recruiting adult patients, who have partial tears of the rotator cuff tendon and persistent shoulder pain after physiotherapy and injection treatments. The randomised controlled trial will compare arthroscopic (keyhole) surgery that cleans, tidies and repairs the tear, to a procedure that just cleans and tidies the tear. The team will monitor how well patients recover firstly over 2 years and then over 5 years.

Similar stories

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Professor David Beard named NIHR Senior Investigator

NDORMS Professor of Musculoskeletal and Surgical Science, David Beard, has been named National Institute of Health Research (NIHR) Senior Investigator.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.